This content is current only at the time of printing. This document was printed on 8 December 2019. A current copy is located at https://apvma.gov.au/node/12791
You are here
Dr Phil Reeves has been appointed to the new role of APVMA Chief Scientist
Dr Phil Reeves has been appointed to the new role of APVMA Chief Scientist.
The APVMA’s Chief Scientist will ensure our regulatory science frameworks and standards continue to meet appropriate national and international standards.
Through engagement with national and international scientific and regulatory networks, the Chief Scientist will identify issues and trends that may impact on the integrity of our regulatory science frameworks and standards and develop appropriate projects and initiatives to enhance our scientific capability.
The role will also provide the Chief Executive Officer and senior staff direct access to independent, expert advice on regulatory decisions and scientific aspects of the APVMA’s regulatory framework, and will manage the APVMA’s Principal Scientists and special projects.
Dr Reeves holds a Bachelor of Veterinary Science (Honours) degree from the University of Queensland and a PhD in pharmacology from the University of Western Australia. He is a Fellow of the Australian and New Zealand College of Veterinary Scientists in veterinary industrial pharmacology and is a registered specialist in veterinary pharmacology.
He comes to this role with both private and public sector experience with his early years as a practicing vet, then later in molecular pharmacology and toxicology research. Since joining the APVMA in 1992, he has held senior positions, most recently as Principal Scientist and Chief Regulatory Scientist Veterinary Medicines.
Dr Reeves has represented Australia at major international forums, including OECD, FAO/WHO and VICH working groups. He has presented more than 100 invited lectures in Australia and overseas and he has published numerous scientific journal articles and book chapters.